Safety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSD

NCT05181995 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

121

Enrollment

INDUSTRY

Sponsor class

Stopped company decision

Conditions

PTSD

Interventions

DRUG: NYX-783
DRUG: Placebo

Sponsor

Aptinyx

Collaborators

[object Object]